Cornell researchers have discovered a way to open one of the major barriers to the brain, called the blood brain barrier, which prevents the entry of therapies to treat brain disorders.
A newly discovered genetic mutation that is found in a subtype of prostate cancer is integral to the disease’s development and growth, according to research from Weill Cornell Medicine scientists.
Cornell researchers investigating why HA treatments have produced mixed results discovered that a molecule, lubricin, helps anchor HA at the tissue surface, which helps to move cartilage into a low-friction regime.
At Cornell's version of TEDx Talks – CURBx – seven undergraduate students explained their humanities and STEM research in five-minute presentations Nov. 21 in McGraw Hall.
An interdisciplinary study led by biomedical engineering professor Claudia Fischbach-Teschl connects breast cancer metastasis to the nanocrystal structure of certain bone regions where metastasis occurs.
Dr. Rahul Sharma has been named emergency physician-in-chief at NewYork-Presbyterian/Weill Cornell Medical Center and chief of the Division of Emergency Medicine at Weill Cornell Medicine.
Anesthesia induces unconsciousness by changing the function of proteins on the surface of a thin membrane that forms a barrier around all cells, according to Weill Cornell Medicine scientists.
Think tofu but with a creepy-crawly, sustainable twist: A Cornell food science team will compete Feb. 14 at the Thought for Food Global Summit in Lisbon, Portugal, with C-fu – a new protein product made entirely of crushed mealworms.
In a Cornell study of rats, researchers engineered a common gut bacteria, which when taken orally, helped control diabetes with the body’s own insulin. The study was published Jan. 27 in the journal Diabetes.
The first Big Red STEM Day exposed high school students from communities underrepresented in science, technology, engineering and mathematics to educational and career opportunities in those fields.